This one-day program is designed for scientists/investigators, students and clinicians with an interest in diabetes.
Specifically, this conference will discuss recent methodologic advances that enable more precise animal and ex vivo disease modeling (using stem cells), which coupled with integration of genomic data, should enable identification of new therapeutic targets to benefit diabetic patients. Additional focus areas will include novel insulin preparations, in vivo beta cell imaging techniques, new glucose sensors, and integrated systems that allow greater communication between glucose sensors and insulin pumps.
As in the past, emphasis will be on the presentation of new and unpublished data, and on vigorous interactions between the audience and speakers.
Tuition is free for all. CME credits available.
Naomi Berrie Diabetes Center
Columbia University Medical Center
Russ Berrie Medical Science Pavilion
1150 St. Nicholas Avenue, Rm 620
New York, NY 10032
To view brochure: